Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339376 · ClinicalTrials.gov registry record · NA
Treating Deep Seizure Foci With Noninvasive Surface Brain Stimulation
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02339376 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT02339376, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The overall goal of this study is to open up the promising treatment of repetitive transcranial magnetic stimulation (rTMS), which has been shown to be effective against seizures in patients with surface neocortical foci, to a much larger population of patients with mesial temporal lobe epilepsy (MTLE) and other forms of epilepsy with deep foci, who are not currently considered good rTMS candidates. The investigators hypothesize that rTMS can modulate the hyperexcitable state in patients with deep seizure foci by targeting its usage to accessible cortical partner regions. In this study the investigators aim 1) to map the functional connectivity of the epileptogenic mesial temporal lobe in patients with medically refractory mesial temporal lobe epilepsy; and 2) to perform a randomized controlled assessment of repetitive transcranial magnetic stimulation protocols applied to specific neocortical targets in mesial temporal lobe epilepsy. The methods used in this study will include magnetic resonance imaging (MRI) of the brain, electroencephalography (EEG), and transcranial magnetic stimulation (TMS).
Interventions
- DEVICE Sham repetitive transcranial magnetic stimulation
- DEVICE Low-frequency repetitive transcranial magnetic stimulation
- DEVICE High-frequency repetitive transcranial magnetic stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-01 |
| Est. Completion | 2021-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02339376
The ClinicalTrials.gov registry entry for NCT02339376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham repetitive transcranial magnetic stimulation is the first listed.
NCT02339376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02339376 about?
NCT02339376 is a clinical study titled "Treating Deep Seizure Foci With Noninvasive Surface Brain Stimulation". The overall goal of this study is to open up the promising treatment of repetitive transcranial magnetic stimulation (rTMS), which has been shown to be effective against seizures in patients with surface neocortical foci, to a much larger population of patients with mesial temporal lobe epilepsy (MT...
What is the current status of trial NCT02339376?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2015-01. Estimated completion is 2021-03-10.
What interventions are being tested in trial NCT02339376?
The interventions under investigation include: Sham repetitive transcranial magnetic stimulation (DEVICE), Low-frequency repetitive transcranial magnetic stimulation (DEVICE), High-frequency repetitive transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT02339376?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.